INSPIRIS valve, Edwards Lifesciences

Edwards Lifesciences Receives FDA Approval for Its New Class of Heart Valves

By MedTech Intelligence Staff
No Comments
INSPIRIS valve, Edwards Lifesciences

The Inspiris Resilia valve is intended for aortic valve replacement.

INSPIRIS valve, Edwards Lifesciences
INSPIRIS valve with inside view of VFit technology. Image courtesy of Edwards Lifesciences.

Last week FDA approved Edwards Lifesciences Corp.’s Inspiris Resilia aortic valve, which the company is calling a new class of resilient heart valves. Intended for surgical aortic valve replacement, the device platform is built on the design of the Carpentier-Edwards Perimount valve, which has 20 years of clinical use behind it. The valve features tissue technology that combines anti-calcification properties, sustained hemodynamic performance and dry storage. Its VFit technology has an expandable frame and includes fluroscopically visible size markers and can be used in future valve-in-valve procedures.

The company plans to launch the valve in the United States early next year. It was launched in Europe earlier this year.

Leave a Reply

Your email address will not be published. Required fields are marked *